Understanding how immune cells affect brain tumors
Myeloid Recruitments and their Role in Brain Tumors
This study is looking at how certain immune cells in the brain, called myeloid cells, affect the growth of glioblastoma tumors and how they respond to cancer treatments, with the goal of finding better ways to help patients like you.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Icahn School of Medicine at Mount Sinai NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-11074675 on NIH RePORTER |
What this research studies
This research investigates the role of myeloid cells, which are a type of immune cell, in the environment of brain tumors, specifically glioblastoma. It aims to understand how these cells contribute to tumor growth and the body's immune response to cancer therapies. By studying different types of myeloid cells that infiltrate tumors, the research seeks to uncover their interactions and how they can be targeted for better treatment outcomes. The approach includes using genetically-engineered mouse models that mimic human brain tumors to observe these processes in action.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients diagnosed with glioblastoma who are seeking innovative treatment options.
Not a fit: Patients with brain tumors other than glioblastoma may not benefit directly from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapies that improve the effectiveness of treatments for brain tumors.
How similar studies have performed: Previous research has shown promise in targeting immune cells in cancer treatment, suggesting that this approach could lead to significant advancements.
Where this research is happening
New York, United States
- Icahn School of Medicine at Mount Sinai — New York, United States (Active)
Researchers
- Principal investigator: Hambardzumyan, Dolores — Icahn School of Medicine at Mount Sinai
- Study coordinator: Hambardzumyan, Dolores
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.